“PHARMACOKINETICS OF SECOND LINE ANTI-TB DRUG (LEVOFLOXACIN) IN MDR-TB PATIENTS”. Scholar: National School of Leadership 8, no. 2.2 (September 29, 2019). Accessed October 24, 2026. https://jconsortium.com/index.php/scholar/article/view/93.